Related Experiment Video

Updated: Mar 8, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.2K

Clinical Profile of Dengue Infection in Immune-compromised Children

Amitabh Singh1, Rachna Seth, Mohit Singla

  • 1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. rakesh_lodha@hotmail.com.

Indian Pediatrics
|February 5, 2017
PubMed

Insights

This study compared dengue in immunocompromised versus immunocompetent children. Immunocompromised children experienced delayed platelet recovery and more liver issues, requiring greater fluid support.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Dengue virus infection is a significant global health concern, particularly in pediatric populations.
  • Understanding the impact of immune status on dengue disease course is crucial for effective management.

Purpose of the Study:

  • To compare clinical and laboratory parameters, illness progression, and outcomes of dengue infection in immunocompromised versus immunocompetent children.
  • To identify specific differences in disease manifestations and recovery between these groups.

Main Methods:

  • Retrospective review of medical records of pediatric patients admitted with confirmed dengue infection.
  • Comparison of key clinical indicators, laboratory findings, and treatment requirements between immunocompromised and immunocompetent cohorts.

Main Results:

  • Statistically significant differences observed in the time to platelet recovery (P=0.03).
  • Increased incidence of hepatic dysfunction noted in the immunocompromised group (P=0.04).
  • Higher fluid requirements were documented in immunocompromised children (P=0.01).

Conclusions:

  • Immunocompromised children with dengue exhibit distinct clinical trajectories compared to their immunocompetent counterparts.
  • These findings highlight the need for tailored monitoring and management strategies for dengue in immunocompromised pediatric patients.

More Related Videos

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

2.2K
Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

19.2K

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405